CSIMarket Company Name, Ticker, Suppliers, else..


Cerevel Therapeutics Holdings Inc   (NASDAQ: CERE)
Other Ticker:  
 

Cerevel Therapeutics Holdings Inc

CERE's Fundamental analysis



Cerevel Therapeutics Holdings Inc 's sales fell in the first quarter of 2024 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded growth of revenues by 0.35 %

Cerevel Therapeutics Holdings Inc net loss increased from $-104 millions, to $-132 millions in first quarter of 2024,

• More on CERE's Growth


Cerevel Therapeutics Holdings Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 48.98 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.05.


• More on CERE's Valuation
 
 Total Debt (Millions $) 338
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 3.11

Cerevel Therapeutics Holdings Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 48.98 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.05.

Cerevel Therapeutics Holdings Inc Price to Book Ratio is at 14.47 lower than Industry Avg. of 32.32. and higher than S&P 500 Avg. of 0.01

• More on CERE's Valuation

•  Market Capitalization (Millions $) 8,165
•  Shares Outstanding (Millions) 182
•  Employees 260
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -460
•  Cash Flow (TTM) (Millions $) 167
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) 338
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 3.11

•  Market Capitalization (Millions $) 8,165
•  Shares Outstanding (Millions) 182
•  Employees 260
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -460
•  Cash Flow (TTM) (Millions $) 167
•  Capital Exp. (TTM) (Millions $) -4





  Ratio
•   Capital Ratio (MRQ) 10.22
•  Total Debt to Equity (MRQ) 0.6
•  Tangible Leverage Ratio (MRQ) 1
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com